当前位置: X-MOL 学术Nat. Commun. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Publisher Correction: miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia.
Nature Communications ( IF 16.6 ) Pub Date : 2018-04-10 , DOI: 10.1038/ncomms16192
Zejuan Li , Hao Huang , Ping Chen , Miao He , Yuanyuan Li , Stephen Arnovitz , Xi Jiang , Chunjiang He , Elizabeth Hyjek , Jun Zhang , Zhiyu Zhang , Abdel Elkahloun , Donglin Cao , Chen Shen , Mark Wunderlich , Yungui Wang , Mary Beth Neilly , Jie Jin , Minjie Wei , Jun Lu , Peter J. M. Valk , Ruud Delwel , Bob Lowenberg , Michelle M. Le Beau , James Vardiman , James C. Mulloy , Nancy J. Zeleznik-Le , Paul P. Liu , Jiwang Zhang , Jianjun Chen

This corrects the article DOI: 10.1038/ncomms1681.

中文翻译:

出版商更正:miR-196b直接针对MLL重排的白血病中的HOXA9 / MEIS1癌基因和FAS肿瘤抑制物。

这将更正文章DOI:10.1038 / ncomms1681。
更新日期:2018-04-10
down
wechat
bug